Stock analysts at Cowen and Company boosted their price target on shares of Furiex Pharmaceuticals (NASDAQ:FURX) to $157.00 in a report issued on Wednesday, Stock Ratings Network.com reports. Cowen and Company’s target price indicates a potential upside of 43.08% from the stock’s previous close.
Shares of Furiex Pharmaceuticals (NASDAQ:FURX) traded up 0.46% on Wednesday, hitting $110.24. The stock had a trading volume of 86,796 shares. Furiex Pharmaceuticals has a one year low of $32.01 and a one year high of $121.97. The stock has a 50-day moving average of $49.53 and a 200-day moving average of $43.53. The company’s market cap is $1.143 billion.
Several other analysts have also recently commented on the stock. Analysts at Ladenburg Thalmann raised their price target on shares of Furiex Pharmaceuticals from $57.00 to $137.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Zacks downgraded shares of Furiex Pharmaceuticals from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday, January 2nd. They now have a $48.90 price target on the stock. Finally, analysts at Zacks upgraded shares of Furiex Pharmaceuticals from an “underperform” rating to an “outperform” rating in a research note to investors on Tuesday, November 12th. They now have a $37.20 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $98.48.
Furiex Pharmaceuticals, Inc is a drug development collaboration company. The Company’s product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.